In a new report, the CDC says a nationwide surveillance program uncovered increases in the percentage of gonorrhea samples that were resistant to one drug or the other, and in the case of azithromycin, the rise in resistant samples was four-fold in 2014 alone. Robert Kirkcaldy, said in an interview with STAT. “The potential for untreatable gonorrhea is a very real possibility in the future,” first author of the report, Dr. Unfortunately, these two drugs might not measure up to the rapidly mutating bug, which is evolving to resist the antibiotic treatments. There are two antibiotics used to treat the STD: azithromycin and ceftriaxone. Some people who contract gonorrhea show no symptoms, while others may notice pain, burning, or discharge in the site of infection - typically the uterus, penis, anus, throat, or mouth. The health risks can also be passed down to offspring, with the potential an eye infection that could be vision-threatening.
Infections caused by Neisseria gonorrhoeae can cause a pelvic inflammatory disease in women, which can lead to a number of serious reproductive problems, like infertility and chronic pelvic pain. The bacteria is becoming resistant to the only two drugs left that treat the STD.Īccording to the Centers for Disease Control and Prevention (CDC), the sexually transmitted disease gonorrhea is the second most commonly reported notifiable disease in the United States - over 350,000 cases were reported in 2014.
0 kommentar(er)
